VNDA Overview
Upcoming Projects (VNDA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (VNDA)
-
Digging into the Phase 3 results for Vanda's fanapt (iloperidone) in treating bipolar depression
Ticker: VNDA
Executed On: Jan 06, 2023 at 03:00 PM EST -
Evaluating the potential of VNDA's Tradipitant in treating Gastroparesis prior to P3 Readout
Ticker: VNDA
Executed On: Feb 02, 2022 at 04:00 PM EST
Expired Projects (VNDA)
-
An in-depth examination of tradipitant, following Vanda’s release of its Motion Sickness results
Ticker: VNDA
Execute By: Aug 23, 2019 -
Discussing the market potential of Vanda's Hetlioz in Jet Lag, prior to the upcoming Phase 2 data release
Ticker: VNDA
Execute By: Mar 26, 2018
Upcoming & Overdue Catalysts (VNDA)
-
Vanda Pharmaceuticals (VNDA) to file NDA for Tradipitant for Gastroparesis to FDA in early 2022
Ticker: VNDA
Future Window: Jan 01, 2022 - Mar 31, 2022
Overdue
Occurred Catalysts (VNDA)
-
Vanda Pharmaceuticals (VNDA) Expected to submit HETLIOZ filing to EU in 2018 for Smith Magenis Syndrome (SMS) indication
Ticker: VNDA
Occurred on: Aug 03, 2020 -
Vanda Pharmaceuticals (VNDA) to submit NDA on Tradipitant for Gastroparesis to EMA in 2020
Ticker: VNDA
Occurred on: Jul 13, 2020 -
Vanda Pharmaceuticals (VNDA) to file for Tradipitant for Pruritus to EMA in 2020
Ticker: VNDA
Occurred on: Feb 25, 2020 -
Vanda Pharmaceuticals (VNDA) to submit NDA for Tradipitant in Pruritus to FDA in 2020
Ticker: VNDA
Occurred on: Feb 25, 2020 -
Vanda Pharmaceuticals (VNDA) Expected to submit HETLIOZ filing to FDA in 2018 for Non-24 sleep-wake disorder pediatric indication
Ticker: VNDA
Occurred on: Aug 19, 2019 -
Vanda Pharma's (VNDA) HETLIOZ (tasimelteon) in Jet Lag Disorder PDUFA date due August 16, 2019
Ticker: VNDA
Occurred on: Aug 19, 2019 -
Vanda Pharmaceuticals (VNDA) Expected to submit HETLIOZ filing to FDA in 2018 for Smith Magenis Syndrome (SMS) indication
Ticker: VNDA
Occurred on: Aug 19, 2019 -
Vanda Pharma receives FDA Update for HETLIOZ in the Treatment of Jet Lag Disorder
Ticker: VNDA
Occurred on: Jul 22, 2019 -
Vanda Pharmaceuticals (VNDA) Expected to submit HETLIOZ filing to FDA in 2018 for jet lag symptoms
Ticker: VNDA
Occurred on: Dec 20, 2018 -
Vanda Pharmaceuticals (VNDA) Phase 2 HETLIOZ trial on Jet Lag symptoms expected to release results in Q1 2018
Ticker: VNDA
Occurred on: Mar 05, 2018 -
Vanda Pharmaceuticals (VNDA) Expected to submit HETLIOZ filing to EU in 2018 for Jet Lag disorder
Ticker: VNDA
Occurred on: Mar 05, 2018 -
Tradipitant Phase 2 trial by Vanda Pharmaceuticals (VNDA) in treating Gastroparesis should see results in fourth quarter of 2017
Ticker: VNDA
Occurred on: Oct 17, 2017 -
Vanda Pharmaceuticals (VNDA) expecting Phase 2 results for Tradipitant clinical trial, testing treatment for Pruritus, in mid-2017
Ticker: VNDA
Occurred on: Sep 13, 2017 -
Vanda Patents Found Valid and Infringed in Fanapt ANDA Litigation
Ticker: VNDA
Occurred on: Aug 25, 2016 -
HETLIOZ is Now Available for the Treatment of Non-24-Hour Sleep-Wake Disorder in Germany
Ticker: VNDA
Occurred on: Aug 01, 2016
Strategic Initiatives (VNDA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
